All Stories

  1. Effectiveness and Safety of the Combination of Paracetamol 1000 mg and Ibuprofen 300 mg Versus Ibuprofen 600 mg in Monotherapy in Acute Low Back Pain: Results from a Phase IV Randomized Study
  2. Efficacy of a Naturally Calcium and Magnesium-Rich Mineral Water on Musculoskeletal Fragility: A Randomized, Double-Blind Controlled Trial
  3. Neurofunctional and Biomechanical Adaptations to Robotic-Assisted Gait Therapy in Cerebral Palsy: A Double Case Study
  4. Efficacy of a Naturally Calcium- and Magnesium-Rich Mineral Water on Musculoskeletal Fragility: A Randomized, Double-Blind Controlled Trial
  5. An Integrated Nutritional and Physical Activity Approach for Osteosarcopenia
  6. What Is the Evidence on Immunomodulators and Immunosuppressants for Progressive Multiple Sclerosis? - A Cochrane Review Summary with Commentary
  7. Transient osteoporosis of the hip and fatty liver disease: Case report and pathogenic hypothesis
  8. Multidisciplinary analysis of ancient human skeletal remains using computed tomography: A case study from Cumae, Italy
  9. New Insights on the miRNA Role in Diabetic Tendinopathy: Adipose-Derived Mesenchymal Stem Cell Conditioned Medium as a Potential Innovative Epigenetic-Based Therapy for Tendon Healing
  10. Role for neurological and immunological resilience in the pathway of the aging muscle powerpenia: InCHIANTI study longitudinal results
  11. Role of Magnesium in Skeletal Muscle Health and Neuromuscular Diseases: A Scoping Review
  12. Effects of a Single Session of Repetitive Transcranial Stimulation in Parkinson Disease
  13. Overview of Cochrane Systematic Reviews for Rehabilitation Interventions in Individuals with Upper Limb Fractures: A Mapping Synthesis
  14. Bone involvement in the early stages of Parkinson’s disease: a case–control study
  15. Neutrophil, lymphocyte count, and neutrophil to lymphocyte ratio predict multimorbidity and mortality—results from the Baltimore Longitudinal Study on Aging follow-up study
  16. The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs
  17. Filamin A cooperates with the androgen receptor in preventing skeletal muscle senescence
  18. What is the role of antidepressants for patients with hip and knee osteoarthritis? A Cochrane Review summary with commentary
  19. Muscle quality, physical performance, and comorbidity are predicted by circulating procollagen type III N-terminal peptide (P3NP): the InCHIANTI follow-up study
  20. Sclerostin: clinical insights in muscle–bone crosstalk
  21. Immersion Ultrasound Therapy in Combination with Manual Therapy in the Treatment of Ischemic Digital Ulcers in Systemic Sclerosis
  22. Pain and Motor Function in Myotonic Dystrophy Type 1: A Cross-Sectional Study
  23. The Role of the Androgen Receptor in Skeletal Muscle and Its Utility as a Target for Restoring Muscle Functions
  24. Radial or Focal Extracorporeal Shock Wave Therapy in Lateral Elbow Tendinopathy: A Real-Life Retrospective Study
  25. Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients
  26. Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic literature review
  27. Nutritional and physical activity issues in frailty syndrome during the COVID-19 pandemic
  28. Anti-sclerostin antibodies: a new frontier in fragility fractures treatment
  29. Effectiveness of High-Intensity Laser Therapy Plus Ultrasound-Guided Peritendinous Hyaluronic Acid Compared to Therapeutic Exercise for Patients with Lateral Elbow Tendinopathy
  30. Effectiveness of combined extracorporeal shock-wave therapy and hyaluronic acid injections for patients with shoulder pain due to rotator cuff tendinopathy: a person-centered approach with a focus on gender differences to treatment response
  31. Functioning issues in inpatients affected by COVID-19-related moderate pulmonary impairment: a real-practice observational study
  32. Efficacy and Effectiveness of Extracorporeal Shockwave Therapy in Patients with Myofascial Pain or Fibromyalgia: A Scoping Review
  33. The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain
  34. The Effectiveness of Behavioral Interventions in Adults with Post-Traumatic Stress Disorder during Clinical Rehabilitation: A Rapid Review
  35. Would Moving Forward Mean Going Back? Comment on Maselli et al. Direct Access to Physical Therapy: Should Italy Move Forward? Int. J. Environ. Res. Public Health 2022, 19, 555
  36. Bone Alterations in Inflammatory Bowel Diseases: Role of Osteoprotegerin
  37. Challenges and Solutions for Musculoskeletal Disorders in Athletes
  38. Bone fragility: conceptual framework, therapeutic implications, and COVID-19-related issues
  39. Complex Regional Pain Syndrome in Athletes: Scoping Review
  40. Physical Agent Modalities in Early Osteoarthritis: A Scoping Review
  41. Epidemiology of Musculoskeletal Injuries in Adult Athletes: A Scoping Review
  42. The Role of Hyaluronic Acid in Sport-Related Tendinopathies: A Narrative Review
  43. Ultrasound Imaging in Sport-Related Muscle Injuries: Pitfalls and Opportunities
  44. Muscle Regeneration and Function in Sports: A Focus on Vitamin D
  45. Role of the Endocannabinoid/Endovanilloid System in the Modulation of Osteoclast Activity in Paget’s Disease of Bone
  46. Complex Regional Pain Syndrome Type I Following Non-Orthopedic Surgery: Case Report and Narrative Review
  47. Natural History of Scoliosis in Children with NF1: An Observation Study
  48. Personalized paths for physical activity: developing a person-centered quantitative function to determine a customized amount of exercise and enhancing individual commitment
  49. Cross Cultural Adaptation and Validation of Italian Version of the Leeds Assessment of Neuropathic Symptoms and Signs Scale and Pain DETECT Questionnaire for the Distinction between Nociceptive and Neuropathic Pain
  50. The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis
  51. Effectiveness of Rehabilitative Intervention on Pain, Postural Balance, and Quality of Life in Women with Multiple Vertebral Fragility Fractures: A Prospective Cohort Study
  52. Efficacy and Effectiveness of Physical Agent Modalities in Complex Regional Pain Syndrome Type I: A Scoping Review
  53. Fractures around Trochanteric Nails: The “Vergilius Classification System”
  54. Personalized Paths for Physical Activity: Developing a Person-Centered Quantitative Function to Determine a Customized Amount of Exercise and Enhancing Individual Commitment
  55. Characterization of Home Working Population during COVID-19 Emergency: A Cross-Sectional Analysis
  56. Transient osteoporosis of the hip and subclinical hypothyroidism: an unusual dangerous duet? Case report and pathogenetic hypothesis
  57. Are TNF‐α blockers effective and safe for Kawasaki disease in children? A Cochrane Review summary with commentary
  58. Choline: An Essential Nutrient for Skeletal Muscle
  59. <p>Multifactorial Assessment of Risk of Falling in 753 Post-Menopausal Women: A Multicenter Cross-Sectional Study by the Italian Group for the Study of Metabolic Bone Diseases</p>
  60. The perspectives of intra-articular therapy in the management of osteoarthritis
  61. Duplicate publication: The Cochrane Rehabilitation eBook: a knowledge translation tool to transfer evidence to different rehabilitation audiences
  62. Effectiveness and tolerability of focal versus radial extracorporeal shock wave therapy in patients affected by plantar fascia enthesopathy
  63. <p>Pharmacological Therapy of Osteoporosis: What’s New?</p>
  64. Do Dietary Supplements and Nutraceuticals Have Effects on Dental Implant Osseointegration? A Scoping Review
  65. Is botulinum toxin effective and safe for motor and phonic tics in patients affected by Tourette syndrome? A Cochrane Review summary with commentary
  66. Neglected femoral neck fractures in cerebral palsy: a narrative review
  67. Adapted physical activity and therapeutic exercise in late-onset Pompe disease (LOPD): a two-step rehabilitative approach
  68. Neuromuscular Diseases and Bone
  69. Denosumab Treatment Improves Health-Related Quality of Life in Osteoporosis: Is It Still an Attractive Topic?
  70. Bone alterations in inflammatory bowel diseases
  71. Pharmacotherapeutic options for complex regional pain syndrome
  72. Mapping the primary outcomes reported in Cochrane systematic reviews regarding stroke with the International Classification of Functioning, Disability and Health domains: current trend and future recommendations
  73. Stentoplasty of calcaneal fractures: Surgical technique and early outcomes
  74. Effectiveness of denosumab on back pain-related disability and quality-of-life in patients with vertebral fragility fractures
  75. Can vitamin D deficiency influence muscle performance in postmenopausal women? A multicenter retrospective study
  76. The Cochrane Rehabilitation eBook: a knowledge translation tool to transfer evidence to different rehabilitation audiences
  77. The Cochrane Rehabilitation eBook: a knowledge translation tool to transfer evidence to different rehabilitation audiences
  78. The combination of vitamin D deficiency and overweight affects muscle mass and function in older post-menopausal women
  79. Muscle Weakness and Falls
  80. Early osteoarthritis: How to define, diagnose, and manage. A systematic review
  81. Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology
  82. Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy
  83. Effectiveness of Calcifediol in Improving Muscle Function in Post-Menopausal Women: A Prospective Cohort Study
  84. Surgical treatment of neglected hip fracture in children with cerebral palsy: case report and review of the literature
  85. Are dietary supplements and nutraceuticals effective for musculoskeletal health and cognitive function? A scoping review
  86. Management of atypical femoral fracture: a scoping review and comprehensive algorithm
  87. Bone involvement and intervertebral disc calcifications in beta-thalassemic patients: a retrospective study
  88. Effects of calcifediol versus cholecalciferol on 25(OH)D3 serum levels, appendicular muscle strength, and physical performance in post-menopausal women
  89. Effects of calcifediol versus cholecalciferol on 25(OH)D3 serum levels, appendicular muscle strength, and physical performance in post-menopausal women
  90. Impact of visceral adiposity on trabecular bone score in obese postmenopausal women: A cohort study
  91. Myths and truths on dietary supplements and nutraceuticals for musculoskeletal health: a scoping review
  92. Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania region database
  93. Back pain-related disability and quality of life in patients affected by vertebral fractures: data from baseline characteristics of population enrolled in Denosumab In Real Practice (DIRP)
  94. Prevalent fragility fractures as risk factor for skeletal muscle function deficit and dysmobility syndrome in post-menopausal women
  95. Hypovitaminosis D is associated with a reduction in upper and lower limb muscle strength and physical performance in post-menopausal women: a retrospective study
  96. Proximal femur geometry assessed by hip structural analysis in hip fracture in women
  97. Algodystrophy (CRPS) in minor orthopedic surgery
  98. Complex regional pain syndrome (CRPS) type I: historical perspective and critical issues
  99. Conservative surgery for the treatment of osteonecrosis of the femoral head: current options
  100. Treatment of complex regional pain syndrome
  101. Determinants of Non-Persistence to Antiosteoporotic Drugs by Using Administrative Database
  102. No. 351 Influence of Sarcopenic Obesity on Osteoporosis and Vertebral Fragility Fractures in Post-Menopausal Women
  103. Physical exercise and sarcopenia in older people: position paper of the Italian Society of Orthopaedics and Medicine (OrtoMed)
  104. NSAIDs and opioids in management of fragility fractures
  105. Sarcopenia in women with vertebral fragility fractures
  106. The contribution of cortical and trabecular tissues to bone strength: insights from denosumab studies